Rifadin Iv Novaplus
NDC Package 0068-0599-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Rifadin Iv Novaplus is a . Marketed by Sanofi-aventis U.s. Llc, this product is identified by NDC 0068-0599 and is authorized under FDA application NDA050627.

Identification & Billing

NDC Package Code
0068-0599-01
Package Description
1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS
Product Code
0068-0599
11-Digit Billing Format
00068059901
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Rifadin Iv Novaplus
Dosage Form
-

Regulatory & Marketing

Labeler Name
Sanofi-aventis U.s. Llc
FDA Application #
NDA050627
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-01-2017
End Marketing Date
10-31-2025
Listing Expiration
10-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0068-0599). Click a package code to view its specific billing and regulatory data.

0068-0599-10
10 CARTON in 1 CARTON / 1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS
0068-0599-10
10 mL in 1 VIAL, GLASS

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0068-0599-01 identifies a specific commercial package of 1 vial, glass in 1 carton / 10 ml in 1 vial, glass of Rifadin Iv Novaplus, labeled by Sanofi-aventis U.s. Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sanofi-aventis U.s. Llc on February 01, 2017. The current certification is valid through October 31, 2025.

How is this Sanofi-aventis U.s. Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00068059901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0068-0599-01
11-Digit CMS (5-4-2)
00068-0599-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.